I
iBio D
D
IBIO
3.80000
USD
-0.31
(-7.43%)
مغلق
حجم التداول
11,207
الربح لكل سهم
-2
العائد الربحي
-
P/E
3
حجم السوق
37,523,769
الأخبار المقالات
العنوان: iBio
القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.